Cipla Shares Drop Amid Competition Concerns Following Keytruda Biosimilar Deal

Indian pharmaceutical company Cipla saw its stock decline after announcing a Keytruda biosimilar partnership with Qilu Pharmaceutical, as investors worry about intensifying market competition.

4 Sept, 05:41 — 4 Sept, 05:41

Post Share

Sources

Showing 1 of 1 sources

moneycontrol8h ago

Cipla shares slip after Keytruda biosimilar deal with Qilu, as competition worries weigh; Morgan Stanley... - Moneycontrol.com

Cipla shares slip after Keytruda biosimilar deal with Qilu, as competition worries weigh; Morgan Stanley... Moneycontrol.com

Read full article →

Cipla Shares Drop Amid Competition Concerns Following Keytruda Biosimilar Deal

Sources

Cipla shares slip after Keytruda biosimilar deal with Qilu, as competition worries weigh; Morgan Stanley... - Moneycontrol.com

Related Stories

Barcelona Surpasses €1 Billion in Annual Revenue for First Time

US Economy Adds 162,000 Jobs in August, Exceeding Forecasts

U.S. Safety Regulators Probe Nearly 1,000 Tesla Cybercabs

VW approves 50,000 additional job cuts and casts doubt on Seat's future